Catalog No.
RVV08004
Expression system
Mammalian Cells
Species reactivity
Hendra virus (isolate Horse/Autralia/Hendra/1994) & Nipah virus
Host species
Mouse
Isotype
IgG1, kappa
Clonality
Monoclonal
Target
G, Glycoprotein G, Attachment glycoprotein, Receptor binding protein, RBP
Concentration
2.4 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
O89343, Q9IH62
Applications
ELISA, FCM, Neutralization
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
HENV-32
Development and Validation of a Differentiating Infected from Vaccinated Animals (DIVA) Enzyme-Linked Immunosorbent Assay (ELISA) Strategy for Distinguishing Between Hendra-Infected and Vaccinated Horses., PMID:40143282
Serological and molecular analysis of henipavirus infections in synanthropic fruit bat and rodent populations in the Centre and North regions of Cameroon (2018-2020)., PMID:39994638
Functional assessment of the glycoproteins of a novel Hendra virus variant reveals contrasting fusogenic capacities of the receptor-binding and fusion glycoproteins., PMID:39704501
Establishing an immune correlate of protection for Nipah virus in nonhuman primates., PMID:39702562
Measures to prevent and treat Nipah virus disease: research priorities for 2024-29., PMID:38964362
Structure and design of Langya virus glycoprotein antigens., PMID:38593070
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates., PMID:38569014
Prefusion stabilization of the Hendra and Langya virus F proteins., PMID:38214525
Structure and design of Langya virus glycoprotein antigens., PMID:37645760
Nipah virus attachment glycoprotein ectodomain delivered by type 5 adenovirus vector elicits broad immune response against NiV and HeV., PMID:37577376
A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses., PMID:37243163
Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein., PMID:36932063
Development and laboratory evaluation of a competitive ELISA for serodiagnosis of Nipah and Hendra virus infection using recombinant Nipah glycoproteins and a monoclonal antibody., PMID:36816187
Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins., PMID:35744614
Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant., PMID:35617431
Architecture and antigenicity of the Nipah virus attachment glycoprotein., PMID:35239409
Sero-Monitoring of Horses Demonstrates the Equivac® HeV Hendra Virus Vaccine to Be Highly Effective in Inducing Neutralising Antibody Titres., PMID:34358146
Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins., PMID:33927387
Prediction of the binding interface between monoclonal antibody m102.4 and Nipah attachment glycoprotein using structure-guided alanine scanning and computational docking., PMID:33106487
Vaccines to Emerging Viruses: Nipah and Hendra., PMID:32991264
Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice., PMID:32340278
Establishment of a Highly Sensitive Assay for Detection of Hepatitis E Virus-Specific Immunoglobulins., PMID:31694975
A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection., PMID:31686101
Superinfective Hepatitis E Virus Infection Aggravates Hepatocytes Injury in Chronic Hepatitis B., PMID:31612388
An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections., PMID:31570878
Henipavirus-like particles induce a CD8 T cell response in C57BL/6 mice., PMID:31561922
Rabies-based vaccine induces potent immune responses against Nipah virus., PMID:31016033
Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody., PMID:30995971
Protection from Hendra virus infection with Canarypox recombinant vaccine., PMID:29263849
The Association of Cytokines and Micronutrients with Hepatitis E Virus Infection During Pregnancy and the Postpartum Period in Rural Bangladesh., PMID:26621563
Structural characterization by transmission electron microscopy and immunoreactivity of recombinant Hendra virus nucleocapsid protein expressed and purified from Escherichia coli., PMID:26196500
Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus., PMID:25948743
Rhabdovirus-based vaccine platforms against henipaviruses., PMID:25320306
Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health., PMID:24572697
Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus., PMID:24508193
Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody., PMID:24130486
Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months., PMID:23867060
Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins., PMID:22915804
Periductal induction of high endothelial venule-like vessels in type 1 autoimmune pancreatitis., PMID:22750968
Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases., PMID:22572886
Henipavirus mediated membrane fusion, virus entry and targeted therapeutics., PMID:22470837
Ephrin-B2 and ephrin-B3 as functional henipavirus receptors., PMID:22227101
A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge., PMID:21689706
Adaptive immune responses during acute uncomplicated and fulminant hepatitis E., PMID:21143520
A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system., PMID:21073718
Targeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: use of an optimized procedure for the coupling of low concentrations of antibody to liposomes., PMID:20429814
A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics., PMID:19646266
Development of a neutralization assay for Nipah virus using pseudotype particles., PMID:19559943
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses., PMID:19216624
Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding., PMID:18799571
Development and Immunogenic Evaluation of a Recombinant Vesicular Stomatitis Virus Expressing Nipah Virus F and G Glycoproteins. [RVV08004]
For research use only. Not for human or drug use.
